GXJ
NVO

Global X Japan’s Novo Nordisk NVO Stock Holding History

Global X Japan’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-33,802
Closed -$1.24M – 406
2026
Q1 		$1.24M Buy
33,802
+2,909
+9% +$138K 0.06% 100
2025
Q4 		$1.57M Buy
30,893
+10,091
+49% +$516K 0.12% 83
2025
Q3 		$1.15M Sell
20,802
-3,403
-14% -$199K 0.1% 62
2025
Q2 		$1.67M Buy
24,205
+8,100
+50% +$551K 0.17% 44
2025
Q1 		$1.12M Sell
16,105
-1,929
-11% -$159K 0.13% 47
2024
Q4 		$1.55M Buy
18,034
+2,254
+14% +$244K 0.19% 44
2024
Q3 		$1.88M Buy
15,780
+1,516
+11% +$202K 0.24% 42
2024
Q2 		$2.04M Buy
+14,264
New +$1.89M 0.29% 43

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Global X Japan's NVO Position: Q2 2026 in Review

Global X Japan sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 33,802 shares — an estimated $1.24M sold.

Global X Japan first reported a position in NVO in Q2 2024 and held it in 8 quarters. The position peaked at $2.04M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Global X Japan reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Global X Japan sold 33,802 Novo Nordisk shares in Q2 2026, an estimated $1.24M.
  • Global X Japan first reported a position in Novo Nordisk in Q2 2024 and held it in 8 quarters.
  • Global X Japan's Novo Nordisk position peaked at $2.04M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Global X Japan's 13F filing for Q2 2026, filed 14 Jul 2026.